https://www.nxtpsychedelics.com/news/articles/psychedelics/atai-life-sciences-announces-dosing-of-first-patient-in-part-2-of-beckley-psytechs-phase-2a-study-exploring-bpl-003-adjunctive-to-ssris-in-patients-with-treatment-resistant-depression/